| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.16 | 6e-05 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-05 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0001 |